| Mrs Teresa O'dom Besson, SLP | |
|
1015 Cinderella Ct, Alexandria, LA 71303-3205 | |
| (318) 481-0835 | |
| Not Available |
| Full Name | Mrs Teresa O'dom Besson |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1015 Cinderella Ct, Alexandria, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023396611 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2007 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Teresa O'dom Besson, SLP 1015 Cinderella Ct, Alexandria, LA 71303-3205 Ph: (318) 481-0835 | Mrs Teresa O'dom Besson, SLP 1015 Cinderella Ct, Alexandria, LA 71303-3205 Ph: (318) 481-0835 |
News Archive
A weight loss drug does not increase cardiovascular events, according to late breaking results from the CAMELLIA-TIMI 61 trial presented today in a Hot Line Session at ESC Congress and published in the New England Journal of Medicine.
Fertility problems, recurrent miscarriages, and pregnancy complications can occur when maternal immunological tolerance of the fetus is impaired. G-rard Chaouat and colleagues from Inserm et Assistance Publique et Universit- Paris Sud Orsay, Hopital Antoine B-cl-re, Clamart Cedex, France, trace the evolution of the science of reproductive immunology to show how the current understanding of maternal-fetal tolerance/dialogue has developed, and its implications for the treatment of infertility disorders
On January 26, 2010, the Food and Drug Administration (FDA) released a key draft guidance document, Guidance for Industry Assessment of Abuse Potential of Drugs. When finalized, this guidance will represent the FDA's current position on the abuse potential of drugs. Noteworthy within the document, Good Laboratory Practices (GLP) specified in the Guidance for Industry S7A Safety 471 Pharmacology Studies for Human Pharmaceuticals and in FDA regulations, 21 CFR 472 part 58, now also apply to abuse potential studies in animals.
In this post in the "Health Affairs Blog," diplomacy and global health consultant Judith Kaufmann writes about the Global Polio Eradication Initiative (GPEI) Independent Monitoring Board quarterly report released last week, stating, "What is really new about this report ... is that it does not, as so many GPEI reports have in the past, point the finger at lack of funding, although there is an obvious concern about the funding gap. Rather, the report looks squarely at changes needed in the management of the global program itself."
› Verified 4 days ago
Elizabeth Landry, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2006 Gus Kaplan Dr, Alexandria, LA 71301 Phone: 318-487-5020 | |
Mr. Brian D Warner, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3912 Parliament Dr, Alexandria, LA 71303 Phone: 318-449-9221 Fax: 318-445-6697 | |
Mrs. Elizabeth Y Erickson, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4515 Eddie Williams Ave, Alexandria, LA 71302 Phone: 318-443-4572 | |
Crystal Hundley, CFY/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2006 Gus Kaplan Dr, Alexandria, LA 71301 Phone: 318-487-5395 Fax: 318-487-5463 | |
Melissa Mctire, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4515 Eddie Williams Ave, Alexandria, LA 71302 Phone: 318-442-5731 | |
Kristen Nicole Franklin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4515 Eddie Williams Ave, Alexandria, LA 71302 Phone: 318-442-5731 |